DIPLOMAT PHARMACY, INC.
DPLO
DPLO was delisted on the 7th of February, 2020.
137 hedge funds and large institutions have $317M invested in DIPLOMAT PHARMACY, INC. in 2019 Q3 according to their latest regulatory filings, with 23 funds opening new positions, 51 increasing their positions, 35 reducing their positions, and 17 closing their positions.
848% more call options, than puts
Call options by funds: $3.33M | Put options by funds: $351K
46% more repeat investments, than reductions
Existing positions increased: 51 | Existing positions reduced: 35
35% more first-time investments, than exits
New positions opened: 23 | Existing positions closed: 17
5% more funds holding
Funds holding: 131 → 137 (+6)
19% less capital invested
Capital invested by funds: $391M → $317M (-$73.6M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AC
Armistice Capital
New York
|
+$12.3M |
| 2 |
Millennium Management
New York
|
+$8.08M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$6.24M |
| 4 |
JP Morgan Chase
New York
|
+$4.26M |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$2.43M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
DM
Deerfield Management
New York
|
-$22.6M |
| 2 |
Capital World Investors
Los Angeles,
California
|
-$9.18M |
| 3 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
-$3.08M |
| 4 |
FCM
Frontier Capital Management
Boston,
Massachusetts
|
-$2.12M |
| 5 |
Invesco
Atlanta,
Georgia
|
-$1.17M |
DPLO Hedge Fund Activity: Q3 2019 in Review
137 of the 4,560 institutional investors tracked by Wall St. Rank reported a position in DIPLOMAT PHARMACY, INC. (DPLO) for Q3 2019, worth a combined $317M — down 19% from $391M a quarter earlier.
Buyers outnumbered sellers: 23 funds opened new DPLO positions and 17 closed out — a net gain of 6 holders — while 51 added to existing stakes and 35 trimmed.
The largest buyer was Armistice Capital, adding an estimated $12.3M. The largest seller was Deerfield Management, cutting an estimated $22.6M.
- 137 institutional investors held DIPLOMAT PHARMACY, INC. (DPLO) as of Q3 2019, up from 131 in Q2 2019.
- Funds reported $317M of DIPLOMAT PHARMACY, INC. stock for Q3 2019, down 19% quarter-over-quarter.
- 23 funds opened new DIPLOMAT PHARMACY, INC. positions in Q3 2019 and 17 closed out, a net change of +6 holders.
- The largest DIPLOMAT PHARMACY, INC. buyer in Q3 2019 was Armistice Capital, an estimated $12.3M added.
- The largest DIPLOMAT PHARMACY, INC. seller in Q3 2019 was Deerfield Management, an estimated $22.6M sold.
Based on aggregated 13F filings for Q3 2019.